Flying rocket

QMS Medical Allied Services Ltd

QMS Medical Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents

QMS Medical Allied Services Ltd

₹ 99.8 -1.43%
17 Oct - close price
qmsmas.com NSE - SME: QMSMEDI
About

Incorporated in 2017, QMS Medical Allied Services Ltd is a manufacturer and distributor of medical devices[1]

Key Points

Business Overview:[1]
QMASL does marketing and distribution of medical products and medical education services to clinics, pharma, medical companies and also to individual users. These devices are sold directly in the brand of the manufacturer and are sold under the brand name Q Devices. Company manages the distribution for other brands viz. 3M, Heine, Rossmax, etc.

Website NSE - SM
  • Market Cap ₹ 193 Cr.
  • Current Price ₹ 99.8
  • High / Low ₹ 122 / 71.5
  • Stock P/E 18.0
  • Book Value ₹ 45.6
  • Dividend Yield 0.50 %
  • ROCE 20.7 %
  • ROE 12.5 %
  • Face Value ₹ 10.0
Edit ratios

Pros

Cons

  • Promoter holding has decreased over last quarter: -5.60%
  • Company has a low return on equity of 12.4% over last 3 years.
  • Company's cost of borrowing seems high

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Healthcare Healthcare Healthcare Equipment & Supplies Medical Equipment & Supplies

Edit Columns
Loading peers table ...

Quarterly Results

Standalone Figures in Rs. Crores / View Consolidated

Jun 2022 Sep 2022 Dec 2022 Mar 2023 Jun 2023 Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025
24.51 27.46 20.70 31.37 25.96 28.64 35.24 32.29 30.37 32.74 39.38 42.38 42.32
22.83 24.57 17.09 28.21 21.30 23.74 30.40 28.34 25.53 27.41 34.04 34.56 36.05
Operating Profit 1.68 2.89 3.61 3.16 4.66 4.90 4.84 3.95 4.84 5.33 5.34 7.82 6.27
OPM % 6.85% 10.52% 17.44% 10.07% 17.95% 17.11% 13.73% 12.23% 15.94% 16.28% 13.56% 18.45% 14.82%
0.17 0.18 0.19 0.19 0.08 0.11 0.15 0.11 0.11 0.09 0.12 0.13 0.15
Interest 0.75 0.66 0.23 0.65 0.59 0.74 0.81 0.99 0.84 1.07 1.31 2.73 1.76
Depreciation 0.19 0.19 0.32 0.37 0.82 0.86 0.88 0.88 0.77 0.83 0.91 0.90 0.76
Profit before tax 0.91 2.22 3.25 2.33 3.33 3.41 3.30 2.19 3.34 3.52 3.24 4.32 3.90
Tax % 26.37% 26.13% 22.77% 33.05% 26.13% 25.22% 25.76% 29.68% 28.44% 25.85% 27.47% 29.17% 31.03%
0.67 1.64 2.51 1.57 2.46 2.56 2.44 1.54 2.40 2.61 2.35 3.07 2.69
EPS in Rs 0.41 1.01 1.30 0.81 1.27 1.33 1.26 0.80 1.24 1.35 1.22 1.59 1.39
Raw PDF

Profit & Loss

Standalone Figures in Rs. Crores / View Consolidated

Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 TTM
0 52 73 122 146 104 122 145 157
0 47 63 105 130 93 104 121 132
Operating Profit 0 5 10 17 17 11 18 23 25
OPM % 12% 9% 13% 14% 11% 11% 15% 16% 16%
0 0 0 0 1 1 0 0 0
Interest 0 0 1 1 2 2 3 6 7
Depreciation 0 0 0 1 1 1 3 3 3
Profit before tax 0 4 9 15 14 9 12 14 15
Tax % 0% 30% 28% 27% 26% 27% 26% 28%
0 3 6 11 11 6 9 10 11
EPS in Rs 19.15 26.63 26.07 3.31 4.66 5.40 5.55
Dividend Payout % 0% 0% 0% 0% 0% 0% 10% 9%
Compounded Sales Growth
10 Years: %
5 Years: 15%
3 Years: 0%
TTM: 24%
Compounded Profit Growth
10 Years: %
5 Years: 11%
3 Years: 2%
TTM: 20%
Stock Price CAGR
10 Years: %
5 Years: %
3 Years: -7%
1 Year: -11%
Return on Equity
10 Years: %
5 Years: 19%
3 Years: 12%
Last Year: 13%

Balance Sheet

Standalone Figures in Rs. Crores / View Consolidated

Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Equity Capital 0.01 0.01 3 4 4 18 18 18
Reserves 0 3 6 17 27 53 61 70
0 5 12 20 32 26 2 28
5 10 12 20 19 22 54 73
Total Liabilities 5 18 33 60 82 118 135 189
0 0 3 10 8 25 24 22
CWIP 0 0 0 0 0 1 2 3
Investments 0 0 0 0 0 0 2 48
5 18 30 50 75 91 108 115
Total Assets 5 18 33 60 82 118 135 189

Cash Flows

Standalone Figures in Rs. Crores / View Consolidated

Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
0 0 4 2 -2 -8 1 18
0 -0 -4 -8 2 -25 -2 -48
0 0 0 7 0 32 -1 -2
Net Cash Flow 0 0 1 1 1 -1 -1 -32

Ratios

Standalone Figures in Rs. Crores / View Consolidated

Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Debtor Days 411 56 56 69 105 137 124 104
Inventory Days 22,891 76 108 82 80 140 172 176
Days Payable 26,124 75 78 73 56 91 90 74
Cash Conversion Cycle -2,822 58 86 77 129 187 205 206
Working Capital Days -91 20 27 28 57 138 244 224
ROCE % 121% 65% 54% 30% 14% 17% 21%

Shareholding Pattern

Numbers in percentages

Dec 2022Mar 2023Sep 2023Mar 2024Sep 2024Mar 2025Jun 2025Sep 2025
73.67% 73.67% 73.67% 73.67% 73.67% 73.67% 73.67% 68.07%
0.71% 1.21% 1.02% 0.01% 0.01% 0.01% 0.01% 0.01%
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 1.60%
25.62% 25.12% 25.32% 26.33% 26.33% 26.33% 26.33% 30.32%
No. of Shareholders 9251,0431,2131,5861,6951,5191,4891,529

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Announcements

Annual reports

Concalls